- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by OXO Chemie
Total 589 results
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Ono Pharmaceutical Co. LtdAstellas Pharma IncCompletedInvolutional OsteoporosisJapan
-
Astellas Pharma IncOno Pharma USA IncCompletedBone Diseases | Osteoporosis | Osteoporosis, PostmenopausalJapan
-
Eli Lilly and CompanyLoxo Oncology, Inc.RecruitingUterine Cervical Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Ovarian Neoplasms | Endometrial Neoplasms | Triple Negative Breast Neoplasms | Pancreatic NeoplasmUnited States
-
Assistance Publique - Hôpitaux de ParisOSO-AIRecruiting
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdNot yet recruitingMuscle-invasive Urothelial CarcinomaJapan
-
Eli Lilly and CompanyLoxo Oncology, Inc.RecruitingBreast CancerUnited States, Spain, Korea, Republic of, China, France, Germany, Japan, Belgium, Italy, Australia, United Kingdom, Canada, Singapore
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingNon-Small Cell Lung CancerChina, Spain, Canada, Israel, Italy, Japan, Korea, Republic of, Taiwan, Australia, Poland, Brazil, Turkey, Belgium, Singapore, Czechia, Romania, Germany, Russian Federation, Greece, Netherlands, Argentina, France, Hong Kong, Mexico, Ukr... and more
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS) | Myeloproliferative Neoplasms (MPNs)United States, Spain, Korea, Republic of, France, Taiwan, Australia, Belgium, Singapore, Israel, Canada, Germany, Finland
-
Ono Pharmaceutical Co. LtdBristol-Myers SquibbCompletedNon-Small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingUrothelial CancerRussian Federation, United States, Brazil, Spain, Chile, Korea, Republic of, Argentina, Australia, Canada, China, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Italy, Japan, Mexico, Netherlands, Norway, Peru, Poland, Romania, Swed... and more
-
Loxo Oncology, Inc.Eli Lilly and CompanyWithdrawnMultiple Sclerosis | Relapsing Multiple SclerosisUnited States, Puerto Rico
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingB-cell Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Korea, Republic of, Australia, Japan, United Kingdom, Italy, Poland, France, Switzerland, Sweden
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruiting
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruiting
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingUrinary Bladder Neoplasms | Muscle-Invasive Bladder CancerRussian Federation, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Finland, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Norway, Portugal, Roman... and more
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingMelanomaArgentina, United States, Australia, Austria, Belgium, Canada, Czechia, Finland, France, Greece, Hungary, Ireland, Italy, Japan, Korea, Republic of, Netherlands, Norway, Poland, Romania, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Bristol-Myers SquibbOno Pharma USA IncCompleted
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingGastric Cancer | Esophageal Adenocarcinoma | Gastroesophageal Junction CancerUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Czechia, France, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Si... and more
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingMetastatic Renal Cell Carcinoma | Advanced Renal Cell CarcinomaUnited States, Israel, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Spain, Sweden, Ta... and more
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.CompletedHealthyUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.CompletedHealthy | Hepatic ImpairmentUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedBrain CancerUnited States, Canada, Belgium, Spain, Australia, Netherlands, United Kingdom, Denmark, Norway, Japan, Sweden, France, Poland, Austria, Germany, Israel, Italy, Russian Federation, Switzerland
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedLung CancerAustralia, China, Romania, Colombia, Ireland, Israel, Japan, Spain, Peru, United States, Brazil, Greece, Singapore, Argentina, Austria, Belgium, Canada, Finland, France, Germany, Hong Kong, Italy, Korea, Republic of, Mexico, Netherlands, ... and more
-
Eli Lilly and CompanyLoxo Oncology, Inc.Terminated
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedSafety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer (CheckMate 907)Non-Small Cell Lung CancerUnited States, Canada, Japan, Romania, South Africa
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedVarious Advanced CancerUnited States, Czechia, Japan, Poland, Australia, Belgium, Finland, Germany, Italy, Spain, Sweden
-
Loxo Oncology, Inc.Eli Lilly and CompanyCompletedHealthyUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedAdvanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell CarcinomaUnited States, France, Canada, Spain, Italy, Belgium, Austria, Denmark, Germany, Australia, Israel, Russian Federation, Czechia, Norway, Poland, Romania, Japan, Argentina, Ireland, Greece, United Kingdom, Brazil, Sweden, Finland
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedUndifferentiated ArthritisJapan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingAdvanced or Metastatic Renal Cell CarcinomaJapan
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruiting
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Bristol-Myers SquibbOno Pharma USA IncCompletedCancer of Head and Neck | Cancer of the Head | Cancer of the NeckJapan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedRenal Cell Carcinoma | Clear-cell Metastatic Renal Cell CarcinomaUnited States, Canada
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Bristol-Myers SquibbIMS Health; OXON EpidemiologyCompletedNon-valvular Atrial Fibrillation
-
Novartis PharmaceuticalsOno Pharmaceutical Co. LtdCompleted
-
Astellas Pharma IncOno Pharmaceutical Co. LtdCompletedOsteoporosis | Bone Loss, Age-RelatedJapan
-
Novartis PharmaceuticalsOno Pharmaceutical Co. LtdCompleted
-
University Hospital FreiburgDr. Köhler Chemie (Alsbach-Hähnlein, Germany); HP-Medica (Augsburg, Germany); GEA (Frederiksberg, Denmark) and other collaboratorsTerminatedLower Extremity IschemiaGermany, Austria